AT:AVH Avita Medical Limited

Avita Medical Limited, a medical device company, develops and distributes regenerative products for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. The company's lead product, ReCell, is used in the treatment of various burns, plastic, reconstructive, and cosmetic procedures. It also offers ReGenerCell for chronic wounds and ReNovaCell for pigmentation. Avita Medical Limited is based in Valencia, California.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol RCEL.

This company has ADRs that trade in the U.S. as the symbol RCEL.

3.08 AUD
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  Australia
Country of incorporation:  Australia
IPO date:  12/31/1999
Stock exchange:    Asx - All Markets
Exchange country:   Australia
Market cap:   363,907,936 AUD
Current dividend yield:   0.00%
Sedol:      6386113

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy